International uniform response criteria for multiple myelomaBrian G.M. Durie, Jesús F. San Miguel, J Bladé et al.|Leukemia|2006Cited by 2.6k
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, J H Lee, Juan José Lahuerta et al.|Leukemia|2011Cited by 721